| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA1161: Sotatercept for treating pulmonary arterial hypertension |
|
Medicine details |
|
| Medicine name | Sotatercept (Winrevair®) |
| Formulation | 45 mg powder and solvent for solution for injection |
| Reference number | 5122 |
| Indication | Treatment for pulmonary arterial hypertension |
| Company | Merck, Sharp & Dohme Ltd |
| BNF chapter | Cardiovascular system |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 08/05/2026 |
| NICE guidance | TA1161: Sotatercept for treating pulmonary arterial hypertension |